The 2019 Modern Radiotherapy for Hematologic Malignancies is a two-day meeting featuring interactive case discussions; educational sessions on the multidisciplinary care of patients with Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, myeloma and leukemia; sessions discussing integration of new technology (i.e., IMRT, VMAT, deep inspiration breath hold, proton beam therapy); new targeted therapies; immunotherapy; treatment guidelines; supportive care; and oral abstract sessions highlighting the most current, evidence-based practices. The goal of this meeting is to provide participants with updates on current clinical and translational initiatives in hematologic malignancies that are relevant to daily clinical practice. Additionally, attendees will be updated on the appropriate integration of these advancements in their daily practice, including indication, patient selection, and combinations of different therapeutic modalities, and management of common toxicities. The program will involve significant audience participation in an effort to adapt to the interest of the audiences and to provide a more meaningful and enjoyable experience.
Statement of Need
It is imperative that physicians treating hematologic malignancies remain current in the state-of-the-art scientific advances and technologies. This two-day meeting provides attendees the opportunity to become more familiar with the most recent clinical trials examining the value of consolidative radiotherapy and gain exposure to the latest science in radiotherapy, hematology-oncology, and radiology related to hematologic malignancies. Attendees need to determine when and how the latest scientific advances will affect their day-to-day practice, and thus be able to narrow competency gaps across the various specialties that focus on treatment of hematologic malignancies. Attendees also need to determine greatest obstacles that hinder implementing scientific advances in radiotherapy for hematologic malignancies into their day-to-day practice.
Upon completion of this live activity, attendees should be able to do the following:
- Discuss the current guideline-based clinical practice in hematologic malignancies, in a case-based format.
- Use case examples to apply current hematologic malignancies guidelines into clinical practice.
- Discuss PET/CT response adaptive radiotherapy protocols for Hodgkin lymphoma and non-Hodgkin lymphoma.
- Apply involved-site radiotherapy (ISRT) for all disease sites – including Hodgkin lymphoma, and non-Hodgkin lymphoma.
- Apply multidisciplinary care in hematologic malignancies for optimal outcomes and discuss the importance of multidisciplinary care with others.
- Describe key advances in immunotherapy and targeted therapy in hematologic malignancies, and discuss special considerations when incorporating radiotherapy, keeping in mind potential overlapping toxicities.
- Integrate recent advances in new technology (i.e., IMRT, VMAT, deep inspiration breath hold, proton therapy) and explain to others how and when to integrate them.
- Describe key advances in imaging and its role in adaptive therapy protocols.
- Distinguish how late effects of radiotherapy, balanced against emerging data on dose-dependent late effects of chemotherapy, affects decision-making.
- Manage toxicities related to the management of hematologic malignancies.
- Summarize key recent advances in the understanding of the biology of hematologic malignancies.
Elements of Competence
This educational forum has been designed to narrow the competency gaps of:
- Patient Care
- Medical Knowledge
- Practice-based Learning and Improvement
- Systems-based Practice
- Patient-centered Care
- Work in Interdisciplinary Teams
- Evidence-based Practice
- Quality Improvement
- Utilize Informatics
- Professional Standing
- Commitment to Lifelong Learning
- Cognitive Expertise
- Evaluation of Performance in Practice
- Interprofessional Communication
- Teams and Teamwork
These are 17 of the 19 core competencies embraced by the American Board of Medical Specialties, the Accreditation Council for Graduate Medical Education, the Institute of Medicine, the American Board of Radiology and the Accreditation Council for Continuing Medical Education.
This meeting is designed to meet the interests of medical oncologists, radiation oncologists, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists and pediatric hematology-oncologists.